The goal of this consensus is to provide a comprehensive set of recommendations in regard to hypertension control strategies for the prevention and management of stroke. This document is intended for prehospital care providers, physicians, allied health professionals, and hospital administrators and healthcare policymakers.
Methods:
Members of the writing group were representatives of the World Stroke Organization and World Hypertension League. The writing group reviewed articles searched from PubMed and Google Scholar using selected search strings. The document was sent to 12 peer reviewers. The writing group considered the feedback from peer reviewers and made revisions accordingly. Every member of the writing group gave their approval of the final document.
Results:
This article details the various techniques for blood pressure (BP) measurement, BP classification, BP and stroke risk, antihypertensive drug therapy for the primary and secondary prevention of stroke, choice of antihypertensive drug therapy, optimal BP targets, non-drug approaches to the prevention of stroke through BP lowering, BP management separately for acute ischemic stroke and spontaneous intracerebral hemorrhage, and the implementation of BP prevention, treatment, and control in the community.
Conclusion:
This article provides general recommendations based on currently available evidence to guide healthcare practitioners caring for adults with hypertension for the prevention and management of stroke. Future studies are needed to better define approaches to hypertension control in the community and high-risk groups.
MillsKTBundyJDKellyTN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation2016; 134: 441–450.
2.
GeldsetzerPManne-GoehlerJMarcusME, et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults. Lancet2019; 394: 652–662.
3.
LawesCMHoornSVRodgersA.Global burden of blood-pressure-related disease, 2001. Lancet2008; 371: 1513–1518.
4.
FeiginLVStarkABJohnsonOC; GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol2021; 20: 795–820.
DrawzPEAgarwalADwyerJP, et al. Concordance between blood pressure in the systolic blood pressure intervention trial and in routine clinical practice. JAMA Intern Med2020; 180: 1655–1663.
7.
WheltonPKPiconeDSPadwalR, et al. Global proliferation and clinical consequences of non-validated automated BP devices. J Hum Hypertens2023; 37: 115–119.
8.
CheungAKWheltonPKMuntnerP, et al. International consensus on standardized clinic blood pressure measurement—a call to action. Am J Med2023; 136: 438–445.
9.
WheltonPKCareyRMAronowWS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension2018; 71: e13–e115.
10.
ManciaGKreutzRBrunströmM, et al. 2023 ESH Guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens2023; 41: 1874–2071.
11.
WheltonPK.Evolution of blood pressure clinical practice guidelines: a personal perspective. Can J Cardiol2019; 35: 570–581.
12.
BueltARichardsAJonesAL.Hypertension: new guidelines from the international society of hypertension. Am Fam Physician2021; 103: 763–765.
13.
Al-MakkiADiPetteDWheltonPK, et al. Hypertension pharmacological treatment in adults: a world health organization guideline executive summary. Hypertension2022; 79: 293–301.
14.
ChobanianAVBakrisGLBlackHR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension2003; 42: 1206–1252.
15.
LewingtonSClarkeRQizilbashNPetoRCollinsR; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet2002; 360: 1903–1913.
16.
RapsomanikiETimmisAGeorgeJ, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people. Lancet2014; 383: 1899–1911.
17.
WheltonSPMcEvoyJWShawL, et al. Association of normal systolic blood pressure level with cardiovascular disease in the absence of risk factors. JAMA Cardiol2020; 5: 1011–1018.
18.
ForouzanfarMHLiuPRothGA, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990–2015. JAMA2017; 317: 165–182.
19.
MuntnerPWheltonPK.Using predicted cardiovascular disease risk in conjunction with blood pressure to guide antihypertensive medication treatment. J Am Coll Cardiol2017; 69: 2446–2456.
20.
WheltonPKPollockBD.Is it time to employ a measure of visit-to-visit variability in clinical practice. Hypertension2017; 70: 227–228.
21.
de BontJJaganathanSDahlquistMPerssonÅStafoggiaMLjungmanP. Ambient air pollution and cardiovascular diseases: an umbrella review of systematic reviews and meta-analyses. J Intern Med2022; 291: 779–800.
22.
NeterJEStamBEKokFJGrobbeeDEGeleijnseJM.Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension2003; 42: 878–884.
23.
FilippiniTMalavoltiMWheltonPKNaskaAOrsiniNVincetiM.Blood pressure effects of sodium reduction: dose-response meta-analysis of experimental studies. Circulation2021; 143: 1542–1567.
24.
VincetiMFilippiniTCrippaAde SesmaisonsAWiseLAOrsiniN.Meta-analysis of potassium intake and the risk of stroke. J Am Heart Assoc2016; 5: e004210.
25.
NealBWuYFengX, et al. Effect of salt substitution on cardiovascular events and death. N Engl J Med2021; 385: 1067–1077.
26.
Ishikawa-TakataKOhtaTTanakaH.How much exercise is required to reduce blood pressure in essential hypertensives: a dose–response study. Am J Hypertens2003; 16: 629–633.
27.
Di FedericoSFilippiniTWheltonPK, et al. Alcohol intake and blood pressure levels: a dose-response meta-analysis of nonexperimental cohort studies. Hypertension2023; 80: 1961–1969.
28.
FuchsSCPoli-de-FigueiredoCEFigueiredo NetoJA, et al. Effectiveness of chlorthalidone plus amiloride for the prevention of hypertension: the PREVER-prevention randomized clinical trial. J Am Heart Assoc2016; 5: e004248.
29.
JaegerBCBressAPBundyJD, et al. Longer-term all-cause and cardiovascular mortality with intensive blood pressure control. JAMA Cardiol2022; 7: 1138–1146.
30.
EttehadDEmdinCAKiranA, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet2016; 387: 957–967.
31.
LawMRMorrisJKWaldNJ.Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ2009; 338: b1665.
32.
ThomopoulosCParatiGZanchettiA. Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials. J Hypertens2014; 32: 2285–2295.
33.
ALLHAT Officers Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA2002; 288: 2981–2997.
34.
HeJOuyangNGuoX, et al. Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial. Lancet2023; 401: 928–938.
35.
MahfoudFManciaGSchmiederRE, et al. Cardiovascular risk reduction after renal denervation according to time in therapeutic systolic blood pressure range. J Am Coll Cardiol2022; 80: 1871–1880.
36.
BundyJDLiCStuchlikP, et al. Systolic blood pressure reduction and risk of cardiovascular disease and mortality. JAMA Cardiol2017; 2: 775–781.
37.
WheltonPKO’ConnellSMillsKTHeJ.Optimal antihypertensive systolic blood pressure: a systematic review and meta-analysis. Hypertension2024; 81: 2329–2339.
38.
BagheriNGilmourBMcRaeI, et al. Community cardiovascular disease risk from cross-sectional general practice clinical data: a spatial analysis. Prev Chronic Dis2015; 12: E26.
39.
GeldsetzerPManne-GoehlerJTheilmannM, et al. Geographic and sociodemographic variation of cardiovascular disease risk in India: a cross-sectional study of 797,540 adults. PLoS Med2018; 15: e1002581.
40.
ACCORD Study Group;CushmanWCEvansGW, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med2010; 362: 1575–1585.
41.
SPRINT Research GROUP;LewisECFineJL, et al. Final report of a trial of intensive versus standard blood-pressure control. N Engl J Med2021; 384: 1921–1930.
42.
KitagawaKYamamotoYArimaH, et al. Effect of standard vs intensive blood pressure control on the risk of recurrent stroke: a randomized clinical trial and meta-analysis. JAMA Neurol2019; 76: 1309–1318.
43.
ESPRIT Study Group;HalkesPHAVan GijnJKappelleLJKoudstaalPJAlgraA.Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet2006; 367: 1665–1673.
44.
PowersWJRabinsteinAAAckersonT, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke2019; 50: e344–418.
45.
SandsetECAndersonCSBathPM, et al. European Stroke Organisation (ESO) guidelines on blood pressure management in acute ischaemic stroke and intracerebral haemorrhage. Eur Stroke J2021; 6: II.
46.
HeranMLindsayPGubitzG, et al. Canadian stroke best practice recommendations: acute stroke management, 7th Edition practice guidelines update, 2022. Can J Neurol Sci2022; 51: 1–31.
47.
NguyenTCastonguayASieglerJ, et al. Mechanical thrombectomy in the late presentation of anterior circulation large vessel occlusion stroke: a guideline from the society of vascular and interventional neurology guidelines and practice standards committee. Stroke Vasc Interv Neurol2022; 3: e000512.
48.
KhuranaDPadmaMVBhatiaR, et al. Recommendations for the early management of acute ischemic stroke: a consensus statement for healthcare professionals from the Indian Stroke Association. J Stroke Med2018; 1: 79–113.
49.
LinCJChungCPChengHM, et al. The 2020 Taiwan Stroke Society guidelines for blood pressure control at the acute stage of ischemic stroke. J Formos Med Assoc2023; 122: 98–105.
50.
LiuLChenWZhouH, et al. Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases. Stroke Vasc Neurol2020; 5: 159–176.
51.
FiehlerJCognardCGallitelliM, et al. European Recommendations on Organisation of Interventional Care in Acute Stroke (EROICAS). Int J Stroke2016; 11: 701–716.
52.
MiyamotoSOgasawaraKKurodaS, et al. Japan stroke society guideline 2021 for the treatment of stroke. Int J Stroke2022; 17: 1039–1049.
53.
VenketasubramanianNPweeKHChenCPL; Singapore Ministry of Health Clinical Practice Guidelines Workgroup on Stroke and Transient Ischaemic Attacks. Singapore ministry of health clinical practice guidelines on stroke and transient ischemic attacks. Int J Stroke2011; 6: 251–258.
BryerAConnorMHaugP, et al. South African guideline for management of ischaemic stroke and transient ischaemic attack 2010: a guideline from the South African Stroke Society (SASS) and the SASS Writing Committee. S Afr Med J2010; 100: 747–778.
56.
Stroke and transient ischaemic attack in over 16s: diagnosis and initial management. NICE Guidance. www.nice.org.uk/guidance/ng128 (2019, accessed 17 June 2024).
57.
GoyalNTsivgoulisGPandhiA, et al. Blood pressure levels post mechanical thrombectomy and outcomes in non-recanalized large vessel occlusion patients. Neurology2017; 89: 540–547.
58.
ShoamaneshAPatrice LindsayMCastellucciLA, et al. Canadian stroke best practice recommendations: management of spontaneous intracerebral hemorrhage, 7th edition update 2020. Int J Stroke2021; 16: 321–341.
59.
GreenbergMSZiaiCWendy CordonnierC, et al. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association/American Stroke Association. Stroke2022; 53: e282–e361.
60.
MaLHuXSongL, et al. The third intensive care bundle with blood pressure reduction in acute cerebral haemorrhage trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial. Lancet2023; 402: 27–40.
VictorRGRavenellJEFreemanA, et al. Effectiveness of a barber-based intervention for improving hypertension control in black men. Arch Intern Med2011; 171: 342–350.
63.
DodaniSBeaylerILewisJSowdersLA.HEALS hypertension control program: training church members as program leaders. Open Cardiovasc Med J2014; 8: 121–127.
64.
KateMPSamuelCSinghS, et al. Community health volunteer for blood pressure control in rural people with stroke in India: pilot randomised trial. J Stroke Cerebrovasc Dis2023; 32: 107107.
65.
DasHSachdevaAKumarH, et al. Outcomes of a hypertension care program based on task-sharing with private pharmacies: a retrospective study from two blocks in rural India. J Hum Hypertens2023; 37: 1033–1039.
66.
AjisegiriWSAbimbolaSTesemaAGOdusanyaOOPeirisDJoshiR.“We just have to help”: community health workers’ informal task-shifting and task-sharing practices for hypertension and diabetes care in Nigeria. Front Public Health2023; 11: 1038062.
67.
GamageDGRiddellMAJoshiR, et al. Effectiveness of a scalable group-based education and monitoring program, delivered by health workers, to improve control of hypertension in rural India: a cluster randomised controlled trial. PLoS Med2020; 17: e1002997.
68.
KaurPKunwarASharmaM, et al. The India Hypertension Control Initiative–early outcomes in 26 districts across five states of India, 2018–2020. J Hum Hypertens2022; 37: 560–567.
69.
MagodoroIMOlivierSGaretaD, et al. Linkage to HIV care and hypertension and diabetes control in rural South Africa: results from the population-based Vukuzazi Study. PLoS Glob Public Health2022; 2: e0001221.
70.
BraininMFeiginVMartinsS, et al. Cut stroke in half: polypill for primary prevention in stroke. Int J Stroke2018; 13: 633–647.
71.
JosephPRoshandelGGaoP, et al.; Polypill Trialists’ Collaboration. Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis. Lancet2021; 398: 1133–1146.
